sanfel/iStock Editorial via Getty Images Boeing (NYSE:BA) announced Saturday the launch of certification flight testing for its 777-9 model, marking a major milestone in getting its largest twin-engine aircraft cleared for deliveries next year. The flight testing was conducted with the participation of the Federal Aviation Administration, aviation news siteContinue Reading
Black_Kira/iStock via Getty Images Fluence Energy (NASDAQ:FLNC) +2.1% in Wednesday’s trading as Truist Securities initiated coverage with a Buy recommendation and $25 price target, saying the energy storage company is “well positioned to drive outsized growth via its improving economies of scale/supply chain position and differentiated tech.” Further, Truist analystContinue Reading
Jumia Technologies (NYSE:JMIA) shares rose 20% on Tuesday, after Benchmark started coverage with a Buy rating and said the company is well positioned to capture the unmet pend-up demand in the African market. Benchmark said as a leading African ecommerce platform, the company is poised to benefit from a demographicContinue Reading
peterschreiber.media Mizuho started coverage of Neumora Therapeutics (NASDAQ:NMRA) with an outperform rating, stating it sees 50%+ upside to the stock if the company reports positive Phase 3 data for its lead drug navacaprant in the treatment of major depressive disorder. The investment bank noted the Phase 3 data is expectedContinue Reading
Bitcoin (BTC-USD) is set to fall 6.5% on a weekly basis, as defunct Japanese exchange Mt. Gox starts its payout process. The oldest cryptocurrency saw a gradual decline throughout the week, and slipped below the $60K mark on Wednesday. BTC dropped below the 200-day moving average on Thursday, as Mt.Continue Reading
sutthirat sutthisumdang H.C. Wainwright initiated coverage of Assertio Holdings (NASDAQ:ASRT) with a buy rating, calling the stock undervalued. The investment bank said it viewed Assertio, formerly known as DepoMed, as “underrated and overlooked due to its checkered history,” which included opioid liability exposure and debt as high as $800M. ItContinue Reading
duoogle H.C. Wainwright initiated coverage of Kyverna Therapeutics (NASDAQ:KYTX) with a neutral rating, stating that it was awaiting more data on the company’s cell therapy KYV-101 before becoming more positive on the stock. The investment bank noted that the company recently shared “lackluster” data on KYV-101 in the treatment ofContinue Reading
sutthirat sutthisumdang Morgan Stanley initiated coverage of Absci (NASDAQ:ABSI) with an overweight rating, noting it sees the stock as “an economical way of gaining exposure to the theme of AI in biotech/drug development.” The investment bank said it sees the stock’s risk-reward skewing to the upside ahead of catalysts andContinue Reading
luismmolina/iStock via Getty Images Kosmos Energy (NYSE:KOS) +1.9% in early trading Wednesday after announcing the start-up of oil production from two development wells at the Winterfell field in the U.S. Gulf of Mexico. A third well at Winterfell is currently being drilled and anticipated to come by the end ofContinue Reading
JHVEPhoto Intuit (NASDAQ:INTU) was in the spotlight on Wednesday as investment firm RBC Capital Markets started coverage on the Turbo Tax maker, citing its successful transition to subscriptions, opportunity from artificial intelligence and rising margins. Shares were little changed in premarket trading. Although roughly 80% of the company’s revenue comesContinue Reading
